These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8111727)

  • 41. Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.
    Kelland LR; Sharp SY; O'Neill CF; Raynaud FI; Beale PJ; Judson IR
    J Inorg Biochem; 1999 Oct; 77(1-2):111-5. PubMed ID: 10626362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparison of DNA complexation with antitumor therapeutic cis-DDP and binuclear bivalent platinum compound containing pyrazine].
    Kas'ianenko NA; Aĭa EE; Bogdanov AA; Kosmotynskaia IuV; Iakovlev KI
    Mol Biol (Mosk); 2002; 36(4):745-52. PubMed ID: 12173482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA interactions of a novel platinum drug, cis-[PtCl(NH3)2(N7-acyclovir)]+.
    Balcarová Z; Kaspárková J; Zákovská A; Nováková O; Sivo MF; Natile G; Brabec V
    Mol Pharmacol; 1998 May; 53(5):846-55. PubMed ID: 9584210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of cis- and trans-dichlorodiammineplatinum(II) on human tumor cell proliferation in diffusion chambers in vivo.
    Ambrose KR; Lowrey JS
    Cancer Res; 1982 May; 42(5):1769-73. PubMed ID: 7039818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication.
    Heiger-Bernays WJ; Essigmann JM; Lippard SJ
    Biochemistry; 1990 Sep; 29(36):8461-6. PubMed ID: 2174701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced cellular uptake of cis-dichlorodiammine-platinum by benzaldehyde.
    Dornish JM; Melvik JE; Pettersen EO
    Anticancer Res; 1986; 6(4):583-8. PubMed ID: 3752939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The major chromatin protein histone H1 binds preferentially to cis-platinum-damaged DNA.
    Yaneva J; Leuba SH; van Holde K; Zlatanova J
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13448-51. PubMed ID: 9391045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of second generation platinum cytostatics on mammalian cell proliferation.
    Keprtová J; Smutná A; Minárová E; Vrána O
    Neoplasma; 1990; 37(2):121-9. PubMed ID: 2188163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The interaction of platinum antitumour drugs with mouse liver mitochondria.
    Rosen M; Figliomeni M; Simpkins H
    Int J Exp Pathol; 1992 Feb; 73(1):61-74. PubMed ID: 1315566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The anti Z-DNA reactivity of Z-DNA forming sequences is affected by platinum antitumor drugs.
    Pérez-Martín JM; Requena JM; Craciunescu D; López MC; Alonso C
    J Biol Chem; 1993 Nov; 268(33):24774-8. PubMed ID: 8227037
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electrochemical genosensing of the interaction between the potential chemotherapeutic agent, cis-bis(3-aminoflavone)dichloroplatinum(II) and DNA in comparison with cis-DDP.
    Erdem A; Kosmider B; Osiecka R; Zyner E; Ochocki J; Ozsoz M
    J Pharm Biomed Anal; 2005 Jul; 38(4):645-52. PubMed ID: 15967292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An investigation of the sequence-specific interaction of cis-diamminedichloroplatinum(II) and four analogues, including two acridine-tethered complexes, with DNA inside human cells.
    Murray V; Motyka H; England PR; Wickham G; Lee HH; Denny WA; McFadyen WD
    Biochemistry; 1992 Dec; 31(47):11812-7. PubMed ID: 1445914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The new antitumor drug cycloplatam: cytotoxicity and DNA interstrand cross-linking].
    Gorbacheva LB; Vasil'eva SV; Makhova EV; Moshkovskaia EIu; Sokolova IS; Tikhomirov AG; Dederer LIu
    Antibiot Khimioter; 1999; 44(4):9-12. PubMed ID: 10483489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of platinum antitumor drug binding to DNA by linked and free intercalators.
    Bowler BE; Lippard SJ
    Biochemistry; 1986 May; 25(10):3031-8. PubMed ID: 3718938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies on cis-DDP, [Pt(Dach)(MePhSO)Cl]+ and [PtNH3)2(N-Py)Cl]+ binding to fumarase.
    Yalçin G
    Drug Metabol Drug Interact; 1995; 12(2):105-15. PubMed ID: 8591689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unwinding of DNA polymerases by the antitumor drug, cis-diamminedichloroplatinum(II).
    Volckova E; Evanics F; Yang WW; Bose RN
    Chem Commun (Camb); 2003 May; (10):1128-9. PubMed ID: 12778700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of combined treatment with platinum complexes and ionizing radiation on DNA in vitro.
    Vrána O; Brabec V
    Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Dec; 50(6):995-1007. PubMed ID: 3491805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dissociation of DNA from histone by reaction of anti-cancer drug cis-diamminedichloroplatinum(II) with DNA-histone complexes used as cellular model.
    Koyama Y; Kikuchi S; Nakagawa S; Kobayashi S
    Chem Pharm Bull (Tokyo); 2007 Apr; 55(4):520-5. PubMed ID: 17409540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sequence-dependent termination of mammalian DNA polymerase reaction by a new platinum compound, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutane-dicarboxylato)-2-plati num(II) monohydrate).
    Iwata M; Izuta S; Suzuki M; Kojima K; Furuhashi Y; Tomoda Y; Yoshida S
    Jpn J Cancer Res; 1991 Apr; 82(4):433-9. PubMed ID: 1904423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Platinum(IV) antitumor agents.
    Blatter EE; Vollano JF; Krishnan BS; Dabrowiak JC
    Prog Clin Biol Res; 1985; 172B():185-91. PubMed ID: 3991707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.